To ask the Secretary of State for Health
(1) what progress has been made by the Department of Health Vascular Programme Board in reviewing recommendations from the National Screening Committee on vascular risk assessment; and when the results of the review will be published;
(2) whether modelling of the economic consequences of different approaches to risk factor assessment and management has been undertaken and the options and the implications for NHS implementation considered as recommended by Sir Muir Gray and the National Screening Committee;
(3) what progress has been made in the Department's consideration of a more integrated approach to vascular risk assessment and management since the publication of the National Institute for Health and Clinical Excellence's draft guidance on lipid modification.
As announced by the Prime Minister in his speech about the national health service on